vs
Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and VINCE HOLDING CORP. (VNCE). Click either name above to swap in a different company.
VINCE HOLDING CORP. is the larger business by last-quarter revenue ($85.1M vs $83.5M, roughly 1.0× BillionToOne, Inc.). BillionToOne, Inc. runs the higher net margin — 6.8% vs 3.2%, a 3.6% gap on every dollar of revenue. On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs 6.2%). BillionToOne, Inc. produced more free cash flow last quarter ($6.5M vs $-5.7M).
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
VINCE. is a contemporary clothing fashion brand founded in 2002. In 2023 Authentic Brands Group purchased its intellectual property in a $76.5 million deal.
BLLN vs VNCE — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $83.5M | $85.1M |
| Net Profit | $5.7M | $2.7M |
| Gross Margin | 69.9% | 49.2% |
| Operating Margin | 11.5% | 6.4% |
| Net Margin | 6.8% | 3.2% |
| Revenue YoY | 117.4% | 6.2% |
| Net Profit YoY | 138.3% | -37.3% |
| EPS (diluted) | $0.10 | $0.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $85.1M | ||
| Q3 25 | $83.5M | $73.2M | ||
| Q2 25 | — | $57.9M | ||
| Q1 25 | — | $80.0M | ||
| Q4 24 | — | $80.2M | ||
| Q3 24 | $38.4M | $74.2M | ||
| Q2 24 | — | $59.2M | ||
| Q1 24 | — | $75.3M |
| Q4 25 | — | $2.7M | ||
| Q3 25 | $5.7M | $12.1M | ||
| Q2 25 | — | $-4.8M | ||
| Q1 25 | — | $-28.3M | ||
| Q4 24 | — | $4.3M | ||
| Q3 24 | $-14.9M | $569.0K | ||
| Q2 24 | — | $4.4M | ||
| Q1 24 | — | $-4.7M |
| Q4 25 | — | 49.2% | ||
| Q3 25 | 69.9% | 50.4% | ||
| Q2 25 | — | 50.3% | ||
| Q1 25 | — | 50.1% | ||
| Q4 24 | — | 50.0% | ||
| Q3 24 | 52.6% | 47.4% | ||
| Q2 24 | — | 50.6% | ||
| Q1 24 | — | 45.4% |
| Q4 25 | — | 6.4% | ||
| Q3 25 | 11.5% | 15.2% | ||
| Q2 25 | — | -7.7% | ||
| Q1 25 | — | -37.1% | ||
| Q4 24 | — | 7.2% | ||
| Q3 24 | -32.9% | 1.5% | ||
| Q2 24 | — | 9.5% | ||
| Q1 24 | — | -2.2% |
| Q4 25 | — | 3.2% | ||
| Q3 25 | 6.8% | 16.5% | ||
| Q2 25 | — | -8.3% | ||
| Q1 25 | — | -35.5% | ||
| Q4 24 | — | 5.4% | ||
| Q3 24 | -38.8% | 0.8% | ||
| Q2 24 | — | 7.4% | ||
| Q1 24 | — | -6.2% |
| Q4 25 | — | $0.21 | ||
| Q3 25 | $0.10 | $0.93 | ||
| Q2 25 | — | $-0.37 | ||
| Q1 25 | — | $-2.25 | ||
| Q4 24 | — | $0.34 | ||
| Q3 24 | $-1.47 | $0.05 | ||
| Q2 24 | — | $0.35 | ||
| Q1 24 | — | $-0.37 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $195.2M | $1.1M |
| Total DebtLower is stronger | $55.0M | — |
| Stockholders' EquityBook value | $-239.5M | $53.4M |
| Total Assets | $327.5M | $246.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $1.1M | ||
| Q3 25 | $195.2M | $777.0K | ||
| Q2 25 | — | $2.6M | ||
| Q1 25 | — | $607.0K | ||
| Q4 24 | — | $892.0K | ||
| Q3 24 | — | $711.0K | ||
| Q2 24 | — | $739.0K | ||
| Q1 24 | — | $357.0K |
| Q4 25 | — | — | ||
| Q3 25 | $55.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $53.4M | ||
| Q3 25 | $-239.5M | $49.3M | ||
| Q2 25 | — | $37.2M | ||
| Q1 25 | — | $41.8M | ||
| Q4 24 | — | $57.1M | ||
| Q3 24 | $-242.9M | $52.4M | ||
| Q2 24 | — | $51.7M | ||
| Q1 24 | — | $47.2M |
| Q4 25 | — | $246.0M | ||
| Q3 25 | $327.5M | $239.0M | ||
| Q2 25 | — | $218.0M | ||
| Q1 25 | — | $222.7M | ||
| Q4 24 | — | $254.7M | ||
| Q3 24 | — | $253.6M | ||
| Q2 24 | — | $223.1M | ||
| Q1 24 | — | $225.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.8M | $-5.1M |
| Free Cash FlowOCF − Capex | $6.5M | $-5.7M |
| FCF MarginFCF / Revenue | 7.7% | -6.7% |
| Capex IntensityCapex / Revenue | 8.8% | 0.7% |
| Cash ConversionOCF / Net Profit | 2.42× | -1.86× |
| TTM Free Cash FlowTrailing 4 quarters | — | $4.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-5.1M | ||
| Q3 25 | $13.8M | $4.2M | ||
| Q2 25 | — | $-11.8M | ||
| Q1 25 | — | $22.7M | ||
| Q4 24 | — | $6.4M | ||
| Q3 24 | — | $-3.2M | ||
| Q2 24 | — | $-3.9M | ||
| Q1 24 | — | $14.8M |
| Q4 25 | — | $-5.7M | ||
| Q3 25 | $6.5M | $2.1M | ||
| Q2 25 | — | $-13.2M | ||
| Q1 25 | — | $21.2M | ||
| Q4 24 | — | $5.1M | ||
| Q3 24 | — | $-3.9M | ||
| Q2 24 | — | $-4.6M | ||
| Q1 24 | — | $14.2M |
| Q4 25 | — | -6.7% | ||
| Q3 25 | 7.7% | 2.9% | ||
| Q2 25 | — | -22.9% | ||
| Q1 25 | — | 26.5% | ||
| Q4 24 | — | 6.4% | ||
| Q3 24 | — | -5.2% | ||
| Q2 24 | — | -7.8% | ||
| Q1 24 | — | 18.9% |
| Q4 25 | — | 0.7% | ||
| Q3 25 | 8.8% | 2.9% | ||
| Q2 25 | — | 2.5% | ||
| Q1 25 | — | 1.9% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 0.9% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | — | 0.7% |
| Q4 25 | — | -1.86× | ||
| Q3 25 | 2.42× | 0.35× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.48× | ||
| Q3 24 | — | -5.61× | ||
| Q2 24 | — | -0.89× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
VNCE
| Vince Wholesale | $52.0M | 61% |
| Vince Direct To Consumer | $33.1M | 39% |
